{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:41:02Z","timestamp":1790872862774,"version":"4.1.0"},"reference-count":52,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1649,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2362.2011.02488.x","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T15:52:34Z","timestamp":1298735554000},"page":"889-897","source":"Crossref","is-referenced-by-count":17,"title":["Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension"],"prefix":"10.1111","volume":"41","author":[{"given":"Andrei","family":"Malinovschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Henrohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon O.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Alving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,25]]},"reference":[{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.93.06091368","article-title":"Increased amount of nitric oxide in exhaled air of asthmatics","volume":"6","author":"Alving","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/thx.2005.056093","article-title":"Exhaled nitric oxide measurements: clinical application and interpretation","volume":"61","author":"Taylor","year":"2006","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(94)90935-0","article-title":"Single-breath nitric oxide measurements in asthmatic patients and smokers","volume":"343","author":"Persson","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1183\/09031936.94.07081501","article-title":"Primarily nasal origin of exhaled nitric oxide and absence in Kartagener\u2019s syndrome","volume":"7","author":"Lundberg","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1183\/09031936.00129806","article-title":"Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide","volume":"30","author":"Tiev","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.09-2090","article-title":"Exhaled nitric oxide in pulmonary diseases: a comprehensive review","volume":"138","author":"Barnes","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/japplphysiol.00950.2003","article-title":"Modeling pulmonary nitric oxide exchange","volume":"96","author":"George","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.200403-408OC","article-title":"Alveolar and airway sites of nitric oxide inflammation in treated asthma","volume":"170","author":"Gelb","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1183\/09031936.02.00202002","article-title":"Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms","volume":"20","author":"Lehtimaki","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/rmed.2001.1204","article-title":"Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis","volume":"96","author":"Hogman","year":"2002","journal-title":"Respir Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ppul.20670","article-title":"Nitric oxide production in PCD: possible evidence for differential nitric oxide synthase function","volume":"42","author":"Paraskakis","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/japplphysiol.91148.2008","article-title":"Basal and induced NO formation in the pharyngo-oral tract influences estimates of alveolar NO levels","volume":"106","author":"Malinovschi","year":"2009","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.rmed.2008.09.009","article-title":"Oral bacteria - the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis","volume":"103","author":"Zetterquist","year":"2009","journal-title":"Respir Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/rccm.200412-1684OC","article-title":"Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy","volume":"172","author":"Girgis","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/ajrccm.158.3.9802066","article-title":"Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension","volume":"158","author":"Kaneko","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB16|cit16","first-page":"1693","article-title":"Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension","volume":"27","author":"Rolla","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1378\/chest.111.1.44","article-title":"Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis","volume":"111","author":"Riley","year":"1997","journal-title":"Chest"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1164\/ajrccm.158.4.9802113","article-title":"Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension","volume":"158","author":"Archer","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1388-9842(00)00116-1","article-title":"Increased nitric oxide in exhaled air in patients with rheumatic heart disease","volume":"3","author":"Golbasi","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.freeradbiomed.2004.06.039","article-title":"Nitric oxide and pulmonary arterial pressures in pulmonary hypertension","volume":"37","author":"Machado","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS19990006","article-title":"Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls","volume":"97","author":"Forrest","year":"1999","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s004080000064","article-title":"High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy","volume":"179","author":"Ozkan","year":"2001","journal-title":"Lung"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1476-5381.2009.00340.x","article-title":"Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways","volume":"157","author":"Pinder","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"H331","DOI":"10.1152\/ajpheart.00583.2009","article-title":"Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitrite","volume":"298","author":"Ingram","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1152\/jappl.1998.85.2.642","article-title":"Single-exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate","volume":"85","author":"Tsoukias","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/japplphysiol.00533.2006","article-title":"A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model","volume":"102","author":"Condorelli","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2004.04.027","article-title":"Inorganic nitrate is a possible source for systemic generation of nitric oxide","volume":"37","author":"Lundberg","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2362.2009.02234.x","article-title":"A catalogue of reporting guidelines for health research","volume":"40","author":"Simera","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1183\/09031936.06.00113705","article-title":"Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters","volume":"28","author":"Malinovschi","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.rmed.2009.12.011","article-title":"A single dose of Sildenafil does not enhance FeNO: a randomised, cross-over and placebo-controlled study","volume":"104","author":"Rothe","year":"2010","journal-title":"Respir Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1183\/09031936.00114207","article-title":"Sildenafil treatment in COPD does not affect stroke volume or exercise capacity","volume":"31","author":"Rietema","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur Respir J"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2362.2011.02488.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thx.2007.090480","article-title":"Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland","volume":"63","author":"National Pulmonary Hypertension Centres of the UK and Ireland","year":"2008","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000083502","article-title":"Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension","volume":"42","author":"Demoncheaux","year":"2005","journal-title":"J Vasc Res"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.ATV.0000168414.06853.f0","article-title":"Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension","volume":"25","author":"Kielstein","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005344-200104000-00016","article-title":"Plasma levels of asymmetrical dimethyl-l-arginine in patients with congenital heart disease and pulmonary hypertension","volume":"37","author":"Gorenflo","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/rheumatology\/ken346","article-title":"Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension","volume":"47","author":"Dimitroulas","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/thx.42.2.131","article-title":"Pulmonary function in advanced pulmonary hypertension","volume":"42","author":"Burke","year":"1987","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ppul.10363","article-title":"Lower airway obstruction, bronchial hyperresponsiveness, and primary pulmonary hypertension in children","volume":"37","author":"Rastogi","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1034\/j.1399-3003.1999.13b18.x","article-title":"Salivary contribution to exhaled nitric oxide","volume":"13","author":"Zetterquist","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1096\/fj.06-7526com","article-title":"Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling","volume":"22","author":"Kirsch","year":"2008","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1164\/rccm.2104003","article-title":"Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease","volume":"165","author":"Girgis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.niox.2008.11.004","article-title":"Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis","volume":"20","author":"Tiev","year":"2009","journal-title":"Nitric Oxide"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thorax.57.6.473","article-title":"Peripheral airway obstruction in primary pulmonary hypertension","volume":"57","author":"Meyer","year":"2002","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/clinchem\/41.6.892","article-title":"Nitrite and nitrate determinations in plasma: a critical evaluation","volume":"41","author":"Moshage","year":"1995","journal-title":"Clin Chem"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00431-008-0803-1","article-title":"Plasma endothelin-1 and nitrate levels in Down\u2019s syndrome with complete atrioventricular septal defect-associated pulmonary hypertension: a comparison with non-Down\u2019s syndrome children","volume":"168","author":"Sungur","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.niox.2008.08.003","article-title":"The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash","volume":"19","author":"Govoni","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1111\/j.1365-2362.2011.02488.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ijir.2009.33","article-title":"Erectile dysfunction and NO: variations of NO penile blood levels before and after sildenafil treatment","volume":"21","author":"Palmerini","year":"2009","journal-title":"Int J Impot Res"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2011.02488.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2011.02488.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T12:14:50Z","timestamp":1685967290000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2011.02488.x"}},"subtitle":["PLASMA NITRITE AND NO EXCHANGE PARAMETERS IN PAH"],"short-title":[],"issued":{"date-parts":[[2011,2,25]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02488.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,25]]}}}